June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Lacking Down’s syndrome candidate region-1 lead corneal opacity via neovascularization.
Author Affiliations & Notes
  • Suguru Nakagawa
    Department of Ophthalmology, University of Tokyo, Tokyo, Japan
    Department of Ophthalmology, Asahi general hospital, Asahi-shi, Chiba, Japan
  • Tetsuya Toyono
    Department of Ophthalmology, University of Tokyo, Tokyo, Japan
  • Takashi Minami
    Dept. Life Science , Kumamoto University, Kumamoto, Japan
  • Tomohiko Usui
    Department of Ophthalmology, University of Tokyo, Tokyo, Japan
  • Footnotes
    Commercial Relationships   Suguru Nakagawa, None; Tetsuya Toyono, None; Takashi Minami, None; Tomohiko Usui, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 1393. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Suguru Nakagawa, Tetsuya Toyono, Takashi Minami, Tomohiko Usui; Lacking Down’s syndrome candidate region-1 lead corneal opacity via neovascularization.. Invest. Ophthalmol. Vis. Sci. 2017;58(8):1393.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Down’s syndrome candidate region (DSCR)-1 (also known as RCAN1) suppresses vascular endothelial growth factor (VEGF)-mediated angiogenesis via calcineurin-NFAT pathway in cancer. However, a role of DSCR1 in development of corneal neovascularization is unknown.

Methods : Corneal neovascularization in 20- to 24-week-old male mice of Dscr1 knockout (Dscr1-/-) mice and Dscr1 transgenic (Dscr1Tg) mice was induced by 10-0 nylon suturing. Angiogenesis were quantified using double staining with CD31. Anti-SDF1 neutral antibody administrations in Dscr1-/- mice were performed by subconjunctival injection. For genome-wide transcription analysis, Affymetrix GeneChip Mouse Genome 430 2.0 Array (Affymetrix, CA, USA) was used. The expression of DSCR-1 of human patients was examined using immunohistochemistry in Formalin-fixed paraffin-embedded (FFPE) specimens of human corneal inflammatory diseases.

Results : Dscr1-/- mice developed spontaneous corneal opacity with age. Corneal angiogenesis were increased in the sutured cornea of Dscr1-/-mice. On the other hand, corneal angiogenesiswas decreased in the sutured cornea of Dscr1Tg mice. Pro-angiogenic Sdf1 expression was upregulated in cornea of Dscr1-/- mice and downregulated in Dscr1Tg mice. Anti- SDF1 administrations attenuated Dscr1-/--induced corneal opacities. Expression of DSCR1 was detected in blood vessels and inflammatory cells in FFPE specimens of human corneal inflammatory diseases.

Conclusions : We demonstrated a connection between the calcineurin inhibitor DSCR1 and corneal angiogenesis. NFAT-SDF-1/CXCR4 signaling axis would be a key regulator for corneal neovascularization.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×